SLC25A19

solute carrier family 25 member 19, the group of Solute carrier family 25

Basic information

Region (hg38): 17:75272981-75289510

Previous symbols: [ "MCPHA" ]

Links

ENSG00000125454NCBI:60386OMIM:606521HGNC:14409Uniprot:Q9HC21AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Amish lethal microcephaly (Strong), mode of inheritance: AR
  • Amish lethal microcephaly (Strong), mode of inheritance: AR
  • progressive demyelinating neuropathy with bilateral striatal necrosis (Strong), mode of inheritance: AR
  • Amish lethal microcephaly (Supportive), mode of inheritance: AR
  • progressive demyelinating neuropathy with bilateral striatal necrosis (Supportive), mode of inheritance: AR
  • Amish lethal microcephaly (Strong), mode of inheritance: AR
  • progressive demyelinating neuropathy with bilateral striatal necrosis (Strong), mode of inheritance: AR
  • Leigh syndrome (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Thiamine metabolism dysfunction syndrome 4; Microcephaly, Amish typeARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Neurologic12185364; 19798730; 20583149
High fat diet has been reported as being beneficial

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SLC25A19 gene.

  • not_provided (111 variants)
  • Inborn_genetic_diseases (37 variants)
  • Amish_lethal_microcephaly (22 variants)
  • not_specified (21 variants)
  • Progressive_demyelinating_neuropathy_with_bilateral_striatal_necrosis (16 variants)
  • SLC25A19-related_disorder (7 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC25A19 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001126121.2. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
36
clinvar
36
missense
10
clinvar
3
clinvar
63
clinvar
9
clinvar
85
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
clinvar
2
Total 11 3 64 45 0

Highest pathogenic variant AF is 0.000025403671

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SLC25A19protein_codingprotein_codingENST00000402418 616519
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.6490.3501257360121257480.0000477
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.5871711940.8810.00001212082
Missense in Polyphen3154.5640.56814564
Synonymous0.5397480.10.9230.00000547654
Loss of Function2.68212.00.1665.19e-7157

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001520.000152
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00007930.0000791
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Mitochondrial transporter mediating uptake of thiamine pyrophosphate (ThPP) into mitochondria. {ECO:0000269|PubMed:18280798}.;
Disease
DISEASE: Thiamine metabolism dysfunction syndrome 4, bilateral striatal degeneration and progressive polyneuropathy type (THMD4) [MIM:613710]: A disease characterized by recurrent episodes of flaccid paralysis and encephalopathy associated with bilateral striatal necrosis and chronic progressive polyneuropathy. {ECO:0000269|PubMed:19798730}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Vitamin B1 (thiamin) metabolism;Purine metabolism;Metabolism;Metabolism of water-soluble vitamins and cofactors;Pyrimidine metabolism;Metabolism of vitamins and cofactors (Consensus)

Recessive Scores

pRec
0.178

Intolerance Scores

loftool
0.128
rvis_EVS
-0.43
rvis_percentile_EVS
25.37

Haploinsufficiency Scores

pHI
0.137
hipred
Y
hipred_score
0.551
ghis
0.590

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
N
gene_indispensability_score
0.460

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Slc25a19
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
deoxynucleotide transport;thiamine pyrophosphate transmembrane transport;thiamine-containing compound metabolic process;thiamine transmembrane transport
Cellular component
nucleus;mitochondrial inner membrane;integral component of mitochondrial inner membrane
Molecular function
thiamine transmembrane transporter activity;deoxynucleotide transmembrane transporter activity;thiamine pyrophosphate transmembrane transporter activity